Amoun Pharmaceutical Industries Company

amoun.com

Amoun established its third state-of-the-art factory (Amoun Pharmaceutical Co.) - designed by John Brown Co. in Chicago following all FDA requirements – and is today considered to be one of the largest and most modern pharmaceutical factories in the Middle East and Africa.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

ASCENTAGE PHARMA ANNOUNCES ITS 9TH ORPHAN DRUG DESIGNATION FROM THE US FDA IN 2020

Ascentage Pharma | January 05, 2021

news image

Ascentage Pharma (6855.HK), an internationally engaged, clinical-stage biotechnology organization occupied with creating novel treatments for malignancies, persistent hepatitis B (CHB), and age-related sicknesses, today reported that the US Food and Drug Administration (FDA) has allowed an Orphan Drug Designation (ODD) to the organization's novel Bcl-2 inhibitor, APG-2575, for the therapy of patients with intense myeloid leukemia (AML). This is the fourth ODD allowed to APG-2575 by the US FD...

Read More

Business Insights

AMPLICORE, INC. ANNOUNCES US FDA CLEARANCE OF FIRST INVESTIGATIONAL NEW DRUG APPLICATION (IND) AND ADDITION OF EXPERIENCED FINANCIAL LEADER TO BOARD

Amplicore, Inc. | July 15, 2022

news image

Amplicore Inc., a Mason, OH-based, early-stage biopharmaceutical company specializing in the development of minimally invasive therapeutic solutions for musculoskeletal disorders, today announced that the Food and Drug Administration has cleared their first application for AM3101, a novel treatment to promote healing of acute meniscal tears. The move enables the initiation of a Department of Defense-sponsored phase 1/2b clinical study in concert with the University of Cincinnati. ...

Read More

Pharma Tech

VALGENESIS AND PHARMENG TECHNOLOGY PARTNER TO MODERNIZE AND DIGITIZE VALIDATION AND COMPLIANCE FOR GLOBAL PHARMA, BIOTECH, MEDICAL DEVICE

PRNewswire | June 07, 2023

news image

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and PharmEng Technology, a global ISO-certified consulting firm focused on life sciences, have partnered to provide a range of regulatory intelligence, GxP compliance, and digitized validation solutions for pharmaceutical, biotechnology, medical device, and nutraceutical companies across the globe. PharmEng Technology has staff all over the world serving companies of all sizes, prov...

Read More

LEVINE LEICHTMAN CAPITAL PARTNERS PORTFOLIO COMPANY CAPSA HEALTHCARE ACQUIRES ROBOPHARMA

Capsa Healthcare | August 14, 2020

news image

Capsa Healthcare ("Capsa"), a portfolio company of Levine Leichtman Capital Partners ("LLCP"), announced today that it has acquired NewRobo Development B.V. and subsidiaries (collectively, "RoboPharma"). RoboPharma, based in Waalwijk, Netherlands, creates and implements pharmacy automation solutions for some of the largest pharmacies in Europe. Capsa is a leading provider of innovative, highly engineered workflow products that increase efficiency and reduce costs, e...

Read More
news image

Pharmacy Market

ASCENTAGE PHARMA ANNOUNCES ITS 9TH ORPHAN DRUG DESIGNATION FROM THE US FDA IN 2020

Ascentage Pharma | January 05, 2021

Ascentage Pharma (6855.HK), an internationally engaged, clinical-stage biotechnology organization occupied with creating novel treatments for malignancies, persistent hepatitis B (CHB), and age-related sicknesses, today reported that the US Food and Drug Administration (FDA) has allowed an Orphan Drug Designation (ODD) to the organization's novel Bcl-2 inhibitor, APG-2575, for the therapy of patients with intense myeloid leukemia (AML). This is the fourth ODD allowed to APG-2575 by the US FD...

Read More
news image

Business Insights

AMPLICORE, INC. ANNOUNCES US FDA CLEARANCE OF FIRST INVESTIGATIONAL NEW DRUG APPLICATION (IND) AND ADDITION OF EXPERIENCED FINANCIAL LEADER TO BOARD

Amplicore, Inc. | July 15, 2022

Amplicore Inc., a Mason, OH-based, early-stage biopharmaceutical company specializing in the development of minimally invasive therapeutic solutions for musculoskeletal disorders, today announced that the Food and Drug Administration has cleared their first application for AM3101, a novel treatment to promote healing of acute meniscal tears. The move enables the initiation of a Department of Defense-sponsored phase 1/2b clinical study in concert with the University of Cincinnati. ...

Read More
news image

Pharma Tech

VALGENESIS AND PHARMENG TECHNOLOGY PARTNER TO MODERNIZE AND DIGITIZE VALIDATION AND COMPLIANCE FOR GLOBAL PHARMA, BIOTECH, MEDICAL DEVICE

PRNewswire | June 07, 2023

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and PharmEng Technology, a global ISO-certified consulting firm focused on life sciences, have partnered to provide a range of regulatory intelligence, GxP compliance, and digitized validation solutions for pharmaceutical, biotechnology, medical device, and nutraceutical companies across the globe. PharmEng Technology has staff all over the world serving companies of all sizes, prov...

Read More
news image

LEVINE LEICHTMAN CAPITAL PARTNERS PORTFOLIO COMPANY CAPSA HEALTHCARE ACQUIRES ROBOPHARMA

Capsa Healthcare | August 14, 2020

Capsa Healthcare ("Capsa"), a portfolio company of Levine Leichtman Capital Partners ("LLCP"), announced today that it has acquired NewRobo Development B.V. and subsidiaries (collectively, "RoboPharma"). RoboPharma, based in Waalwijk, Netherlands, creates and implements pharmacy automation solutions for some of the largest pharmacies in Europe. Capsa is a leading provider of innovative, highly engineered workflow products that increase efficiency and reduce costs, e...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us